Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.
Energy & Infrastructure Analyst Lewis and Fixed Income Strategist Malley discuss bitcoin mining trends and themes across the capital ...
Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.
Agree Realty (NYSE:ADC – Free Report) had its target price decreased by Mizuho from $80.00 to $74.00 in a research report ...
BTIG raised the firm’s price target on MoonLake Immunotherapeutics (MLTX) to $81 from $71 and keeps a Buy rating on the shares. The firm ...
FREYR Battery Inc (FREY) stock saw a decline, ending the day at $2.6 which represents a decrease of $-0.16 or -5.80% from the prior close of $2.76. The stock opened at $2.63 and touched a low of $2.55 ...
FiscalNote Holdings Inc (NOTE) stock saw a decline, ending the day at $1.17 which represents a decrease of $-0.16 or -12.03% from the prior close of $1.33. The stock opened at $1.28 and touched a low ...
Last week, BTIG analyst Jake Fuller reiterated a Buy rating on Uber Technologies (UBER) stock with a price target of $90. The analyst remains bullish on the ride-hailing company but expects its Q4 ...
Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) has been assigned a consensus recommendation of “Buy” from the fourteen research firms that are covering the firm, MarketBeat Ratings reports.
BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...
BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical ...
BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, the firm’s receipt data was “more ...